Joseph Vijai

18.7k total citations
62 papers, 976 citations indexed

About

Joseph Vijai is a scholar working on Genetics, Cancer Research and Molecular Biology. According to data from OpenAlex, Joseph Vijai has authored 62 papers receiving a total of 976 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Genetics, 20 papers in Cancer Research and 18 papers in Molecular Biology. Recurrent topics in Joseph Vijai's work include Cancer Genomics and Diagnostics (15 papers), BRCA gene mutations in cancer (13 papers) and Genomics and Rare Diseases (9 papers). Joseph Vijai is often cited by papers focused on Cancer Genomics and Diagnostics (15 papers), BRCA gene mutations in cancer (13 papers) and Genomics and Rare Diseases (9 papers). Joseph Vijai collaborates with scholars based in United States, India and Canada. Joseph Vijai's co-authors include Kenneth Offit, Mark E. Robson, Zsofia K. Stadler, Kasmintan A. Schrader, Michael F. Walsh, Kurupath Radhakrishnan, Katherine L. Nathanson, Susan M. Domchek, Fergus J. Couch and Shabeesh Balan and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Joseph Vijai

54 papers receiving 963 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Joseph Vijai 489 332 298 202 194 62 976
Elias Obeid 192 0.4× 189 0.6× 215 0.7× 335 1.7× 75 0.4× 41 671
Johanna G. H. van Nes 122 0.2× 288 0.9× 349 1.2× 681 3.4× 160 0.8× 31 1.2k
Jordan Lerner‐Ellis 381 0.8× 569 1.7× 223 0.7× 128 0.6× 191 1.0× 62 1.3k
Ritsuto Fujiwaki 103 0.2× 357 1.1× 206 0.7× 215 1.1× 46 0.2× 55 834
Marianne E. Greene 299 0.6× 626 1.9× 128 0.4× 170 0.8× 73 0.4× 20 1.3k
Fiona Knox 415 0.8× 220 0.7× 554 1.9× 588 2.9× 336 1.7× 26 1.2k
Lola Anagnostaki 110 0.2× 295 0.9× 314 1.1× 435 2.2× 162 0.8× 38 861
Alexander Puhl 98 0.2× 377 1.1× 205 0.7× 346 1.7× 37 0.2× 17 924
Hector Arango 373 0.8× 455 1.4× 221 0.7× 329 1.6× 106 0.5× 15 1.2k
Dalin Li 90 0.2× 210 0.6× 130 0.4× 296 1.5× 62 0.3× 27 650

Countries citing papers authored by Joseph Vijai

Since Specialization
Citations

This map shows the geographic impact of Joseph Vijai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Vijai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Vijai more than expected).

Fields of papers citing papers by Joseph Vijai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Vijai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Vijai. The network helps show where Joseph Vijai may publish in the future.

Co-authorship network of co-authors of Joseph Vijai

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Vijai. A scholar is included among the top collaborators of Joseph Vijai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Vijai. Joseph Vijai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ghione, Paola, Diana Mandelker, Maria E. Arcila, et al.. (2025). BRCA1/2 impact on the development of implant-associated lymphoma in women with breast cancer and textured implants. Blood Advances. 9(17). 4436–4443.
2.
Zhang, Yiwen, Konrad H. Stopsack, Adam S. Kibel, et al.. (2025). Identifying Patients at Risk of Early Lethal Prostate Cancer by Integrating Family History, Polygenic Risk Score, Rare Variants in DNA Repair Genes, and Lifestyle Factors. European Urology Oncology. 1 indexed citations
3.
Stopsack, Konrad H., Joseph Vijai, Jacob E. Berchuck, et al.. (2024). Germline DNA Damage Repair Variants and Prognosis of Patients with High-Risk or Metastatic Prostate Cancer. Clinical Cancer Research. 31(1). 122–129. 5 indexed citations
5.
Ghione, Paola, Maria E. Arcila, Joseph Vijai, et al.. (2023). BRCA1/2 MUTATIONS IMPACT ON THE DEVELOPMENT OF BREAST IMPLANT‐ASSOCIATED LYMPHOMA (BIA‐ALCL) IN WOMEN WITH BREAST CANCER RECONSTRUCTED WITH TEXTURED BREAST IMPLANTS. Hematological Oncology. 41(S2). 193–194. 1 indexed citations
6.
Song, Xiaoyu, Meng Ru, Zoe Steinsnyder, et al.. (2022). SNPs at SMG7 Associated with Time from Biochemical Recurrence to Prostate Cancer Death. Cancer Epidemiology Biomarkers & Prevention. 31(7). 1466–1472. 3 indexed citations
7.
Delavar, Arash, Danielle Novetsky Friedman, Joseph Vijai, et al.. (2020). Utilization of clinical genetic counseling among childhood and young adult cancer survivors in a registry trial. Journal of Community Genetics. 11(4). 501–504.
8.
Ravichandran, Vignesh, Yelena Kemel, Michael F. Walsh, et al.. (2019). Toward automation of germline variant curation in clinical cancer genetics. Genetics in Medicine. 21(9). 2116–2125. 21 indexed citations
9.
Artomov, Mykyta, Joseph Vijai, Grace Tiao, et al.. (2019). Case–control analysis identifies shared properties of rare germline variation in cancer predisposing genes. European Journal of Human Genetics. 27(5). 824–828. 4 indexed citations
10.
Lencz, Todd, Jin Yu, Cameron D. Palmer, et al.. (2018). High-depth whole genome sequencing of an Ashkenazi Jewish reference panel: enhancing sensitivity, accuracy, and imputation. Human Genetics. 137(4). 343–355. 15 indexed citations
11.
O’Donnell, Peter H., Shaheen Alanee, Kelly Stratton, et al.. (2016). Clinical Evaluation of Cisplatin Sensitivity of Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer. Clinical Genitourinary Cancer. 14(6). 511–517. 5 indexed citations
12.
Hayes, James E., Gosia Trynka, Joseph Vijai, et al.. (2015). Tissue-Specific Enrichment of Lymphoma Risk Loci in Regulatory Elements. PLoS ONE. 10(9). e0139360–e0139360. 3 indexed citations
13.
Shah, Sohela, Yonghwan Kim, Irina Ostrovnaya, et al.. (2013). Assessment of SLX4 Mutations in Hereditary Breast Cancers. PLoS ONE. 8(6). e66961–e66961. 34 indexed citations
14.
15.
Xu, Xing, Joseph Vijai, Kenneth Offit, et al.. (2013). Variants at IRX4 as prostate cancer expression quantitative trait loci. European Journal of Human Genetics. 22(4). 558–563. 28 indexed citations
16.
Vijai, Joseph, Tomas Kirchhoff, David Gallagher, et al.. (2011). Genetic architecture of prostate cancer in the Ashkenazi Jewish population. British Journal of Cancer. 105(6). 864–869. 9 indexed citations
17.
Ratnapriya, Rinki, et al.. (2010). A locus for juvenile myoclonic epilepsy maps to 2q33–q36. Human Genetics. 128(2). 123–130. 11 indexed citations
18.
Comen, Elizabeth, Mithat Gönen, Ana Dutra-Clarke, et al.. (2010). Discriminatory accuracy and potential clinical utility of genomic profiling for breast cancer risk in BRCA-negative women. Breast Cancer Research and Treatment. 127(2). 479–487. 14 indexed citations
19.
Somanath, Payaningal R., Joseph Vijai, Julia V. Kichina, Tatiana V. Byzova, & Eugene Kandel. (2009). The role of PAK-1 in activation of MAP kinase cascade and oncogenic transformation by Akt. Oncogene. 28(25). 2365–2369. 51 indexed citations
20.
Vijai, Joseph, et al.. (2003). Clinical characteristics of a South Indian cohort of juvenile myoclonic epilepsy probands. Seizure. 12(7). 490–496. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026